vs
LifeMD, Inc.（LFMD）与湘南美容医疗集团（SBC）财务数据对比。点击上方公司名可切换其他公司
湘南美容医疗集团的季度营收约是LifeMD, Inc.的5.6倍（$39.6M vs $7.1M）。LifeMD, Inc.净利率更高（282.0% vs 35.9%，领先246.1%）。LifeMD, Inc.同比增速更快（5.0% vs -10.9%）。湘南美容医疗集团自由现金流更多（$51.2M vs $-3.4M）。过去两年湘南美容医疗集团的营收复合增速更高（-15.0% vs -60.0%）
SBI人寿保险有限公司是一家印度人寿保险公司，由印度国家银行（SBI）与法国金融机构法国巴黎保险集团合资成立，是印度寿险市场的知名从业机构，为当地民众提供各类人寿保险相关产品与服务。
湘南美容医疗集团是总部位于日本的知名医疗服务提供商，核心业务覆盖美容整形、皮肤科诊疗、抗衰老健康护理等领域，在日本各地运营大量连锁诊所，同时服务本地居民及赴日就医的国际游客。
LFMD vs SBC — 直观对比
营收规模更大
SBC
是对方的5.6倍
$7.1M
营收增速更快
LFMD
高出15.9%
-10.9%
净利率更高
LFMD
高出246.1%
35.9%
自由现金流更多
SBC
多$54.6M
$-3.4M
两年增速更快
SBC
近两年复合增速
-60.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $39.6M |
| 净利润 | $20.0M | $14.2M |
| 毛利率 | 40.2% | 73.1% |
| 营业利润率 | -87.9% | 32.5% |
| 净利率 | 282.0% | 35.9% |
| 营收同比 | 5.0% | -10.9% |
| 净利润同比 | 742.5% | 117.2% |
| 每股收益（稀释后） | — | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFMDSBC
| Q4 25 | $7.1M | $39.6M | ||
| Q3 25 | $60.2M | $43.4M | ||
| Q2 25 | $62.7M | $43.4M | ||
| Q1 25 | $64.1M | $47.3M | ||
| Q4 24 | $6.7M | $44.4M | ||
| Q3 24 | $53.3M | $53.1M | ||
| Q2 24 | $50.7M | $53.1M | ||
| Q1 24 | $44.1M | $54.8M |
净利润LFMDSBC
| Q4 25 | $20.0M | $14.2M | ||
| Q3 25 | $-3.8M | $12.8M | ||
| Q2 25 | $-1.6M | $2.5M | ||
| Q1 25 | $-183.8K | $21.5M | ||
| Q4 24 | $-3.1M | $6.5M | ||
| Q3 24 | $-4.7M | $2.8M | ||
| Q2 24 | $-6.9M | $18.5M | ||
| Q1 24 | $-6.8M | $18.8M |
毛利率LFMDSBC
| Q4 25 | 40.2% | 73.1% | ||
| Q3 25 | 87.7% | 70.6% | ||
| Q2 25 | 88.1% | 69.2% | ||
| Q1 25 | 86.5% | 79.7% | ||
| Q4 24 | -0.8% | 76.3% | ||
| Q3 24 | 90.6% | 81.5% | ||
| Q2 24 | 90.1% | 74.2% | ||
| Q1 24 | 89.6% | 72.1% |
营业利润率LFMDSBC
| Q4 25 | -87.9% | 32.5% | ||
| Q3 25 | -3.3% | 36.6% | ||
| Q2 25 | -0.7% | 33.6% | ||
| Q1 25 | 1.5% | 51.1% | ||
| Q4 24 | -58.2% | 10.6% | ||
| Q3 24 | -7.5% | 26.1% | ||
| Q2 24 | -12.4% | 51.4% | ||
| Q1 24 | -14.0% | 44.6% |
净利率LFMDSBC
| Q4 25 | 282.0% | 35.9% | ||
| Q3 25 | -6.3% | 29.6% | ||
| Q2 25 | -2.6% | 5.7% | ||
| Q1 25 | -0.3% | 45.4% | ||
| Q4 24 | -46.1% | 14.7% | ||
| Q3 24 | -8.7% | 5.3% | ||
| Q2 24 | -13.6% | 34.8% | ||
| Q1 24 | -15.3% | 34.2% |
每股收益（稀释后）LFMDSBC
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | $-0.05 | $0.02 | ||
| Q1 25 | $-0.02 | $0.21 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.13 | $0.03 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $164.1M |
| 总债务越低越好 | — | $42.8M |
| 股东权益账面价值 | $23.2M | $248.3M |
| 总资产 | $70.4M | $380.4M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LFMDSBC
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | $36.2M | $152.7M | ||
| Q1 25 | $34.4M | $132.1M | ||
| Q4 24 | $35.0M | $125.0M | ||
| Q3 24 | $37.6M | $137.4M | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.1M | — |
总债务LFMDSBC
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | $15.9M | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LFMDSBC
| Q4 25 | $23.2M | $248.3M | ||
| Q3 25 | $1.3M | $248.0M | ||
| Q2 25 | $-1.8M | $244.6M | ||
| Q1 25 | $-2.3M | $226.4M | ||
| Q4 24 | $-9.1M | $195.1M | ||
| Q3 24 | $-7.7M | $205.0M | ||
| Q2 24 | $-4.2M | $8.8M | ||
| Q1 24 | $-845.3K | $9.0M |
总资产LFMDSBC
| Q4 25 | $70.4M | $380.4M | ||
| Q3 25 | $66.0M | $321.4M | ||
| Q2 25 | $73.6M | $315.3M | ||
| Q1 25 | $73.6M | $284.6M | ||
| Q4 24 | $76.1M | $266.1M | ||
| Q3 24 | $72.6M | $296.5M | ||
| Q2 24 | $63.8M | $19.5M | ||
| Q1 24 | $61.5M | $19.8M |
负债/权益比LFMDSBC
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.3M | $52.0M |
| 自由现金流经营现金流 - 资本支出 | $-3.4M | $51.2M |
| 自由现金流率自由现金流/营收 | -48.5% | 129.3% |
| 资本支出强度资本支出/营收 | 2.2% | 2.0% |
| 现金转化率经营现金流/净利润 | -0.16× | 3.66× |
| 过去12个月自由现金流最近4个季度 | $6.4M | $23.3M |
8季度趋势，按日历期对齐
经营现金流LFMDSBC
| Q4 25 | $-3.3M | $52.0M | ||
| Q3 25 | $-147.1K | $-20.9M | ||
| Q2 25 | $8.6M | $-8.3M | ||
| Q1 25 | $3.1M | $1.9M | ||
| Q4 24 | $1.1M | $-7.3M | ||
| Q3 24 | $6.7M | $5.0M | ||
| Q2 24 | $4.5M | $19.2M | ||
| Q1 24 | $5.2M | $3.7M |
自由现金流LFMDSBC
| Q4 25 | $-3.4M | $51.2M | ||
| Q3 25 | $-944.4K | $-20.9M | ||
| Q2 25 | $7.8M | $-8.6M | ||
| Q1 25 | $2.9M | $1.7M | ||
| Q4 24 | $875.4K | $-7.9M | ||
| Q3 24 | $6.3M | $4.6M | ||
| Q2 24 | $3.9M | $18.3M | ||
| Q1 24 | $5.0M | $3.0M |
自由现金流率LFMDSBC
| Q4 25 | -48.5% | 129.3% | ||
| Q3 25 | -1.6% | -48.3% | ||
| Q2 25 | 12.5% | -19.9% | ||
| Q1 25 | 4.6% | 3.5% | ||
| Q4 24 | 13.0% | -17.8% | ||
| Q3 24 | 11.7% | 8.7% | ||
| Q2 24 | 7.7% | 34.5% | ||
| Q1 24 | 11.4% | 5.4% |
资本支出强度LFMDSBC
| Q4 25 | 2.2% | 2.0% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.3% | 0.7% | ||
| Q1 25 | 0.2% | 0.5% | ||
| Q4 24 | 2.9% | 1.3% | ||
| Q3 24 | 0.8% | 0.8% | ||
| Q2 24 | 1.3% | 1.6% | ||
| Q1 24 | 0.4% | 1.3% |
现金转化率LFMDSBC
| Q4 25 | -0.16× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFMD
暂无分部数据
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
